HELLP Syndrome

27 registered clinical trials studyying HELLP Syndrome — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregn NCT07510568	St Mary's Hospital, Lacor	Phase 4
Not Yet Recruiting	Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome. NCT07377786	Sohag University	—
Recruiting	Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia NCT07151339	University Hospital Schleswig-Holstein	—
Not Yet Recruiting	Preeclampsia Intervention Netherlands NCT06452498	Amsterdam UMC	Phase 3
Completed	Analysis of Biological Progression and Regression of HELLP Syndrome in Time NCT06758960	CHU Mohammed VI Marrakech	—
Terminated	Complement Regulation to Undo Systemic Harm in Preeclampsia NCT04725812	Cedars-Sinai Medical Center	Phase 2
Completed	Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring NCT04823949	Prisma Health-Upstate	N/A
Unknown	Liver Disease in Pregnancy NCT03834285	King's College Hospital NHS Trust	—
Unknown	TTP and aHUS in Complicated Pregnancies NCT03605511	University College, London	—
Completed	General Anesthesia Versus Spinal Anesthesia in Patients of HELLP Syndrome NCT03111446	Assiut University	N/A
Completed	Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascul NCT03455387	Centre Hospitalier Metropole Savoie	—
Completed	Correlation of Survival in Puerperae by Electrical Impedance Tomography NCT03715647	Amazon University	—
Recruiting	PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis NCT05500989	Maastricht University Medical Center	—
Unknown	A Randomized Control Trial of Vitamin D Prophylaxis in the Prevention of Hypertensive Disorders of Pregnancy NCT02920593	Stony Brook University	Phase 4
Completed	Effect of Acetaminophen on Postpartum Blood Pressure Control in Preeclampsia With Severe Features NCT02911701	University of New Mexico	Phase 4
Unknown	Women Specific Cardiac Recovery After Preeclampsia NCT02807324	Maastricht University Medical Center	—
Completed	Influence of Conditional Workout Postpartum on Arterial Stiffness Among Women With Status After Preeclampsia, NCT02754778	Martin-Luther-Universität Halle-Wittenberg	N/A
Completed	Free DNA and Nucleosome Concentrations in Pathological Pregnancies NCT01736826	Centre Hospitalier Universitaire de Nīmes	—
Completed	Immature Platelet Fraction as a Promising Biomarker in Prediction Outcome of HELLP Syndrome NCT03232359	AYMAN ABDELKADER MOHAMED ABDELKADER	—
Completed	Promising Bimarker Prediction of Outcome of HELLP Syndrome. NCT03246542	AYMAN ABDELKADER MOHAMED ABDELKADER	—
Completed	Early Vascular Adjustments to Prevent Preeclampsia NCT04216706	Maastricht University Medical Center	—
Unknown	Pancreatic Stone Protein (PSP) in Pregnant Women NCT02247297	Nicole Ochsenbein	—
Recruiting	The Preeclampsia Registry NCT06377878	Preeclampsia Foundation	—
Terminated	Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome NCT00711841	Instituto Materno Infantil Prof. Fernando Figueira	Phase 4
Unknown	Dexamethasone Efficacy in HELLP I Syndrome NCT01138839	Universidad del Valle, Colombia	Phase 3
Completed	RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil NCT00097110	NICHD Global Network for Women's and Children's Health	Phase 3
Completed	Calcium for Pre-Eclampsia Prevention (CPEP) NCT00000534	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Phase 3